Reuters talks to users like Allison Vecchio, 42, who take supplements for GLP-1 side effects such as stomach trouble and brittle nails, while doctors and regulators voice caution.
Recap by typeshit. Full story at Reuters on MSN.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
The two drugs brought in $14.9 billion of Lilly's $23.0 billion fiscal Q2 revenue while US prices fell 9%, Trefis says. The Q3 report is expected around October 29.
Novo Nordisk reports the result for its experimental next-generation drug in women with obesity or overweight, based on newly analyzed trial data.
Loading…